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CME: Tuberculosis and HIV
On a global scale, South Africa (SA) is disproportionately 
affected by the epidemics of both tuberculosis (TB) and human 
immunodeficiency virus 1 (HIV-1), and the intersection of these 
two diseases has resulted in an unprecedented disease burden in 
our country. It is estimated that 12.2% of South Africans are HIV-
infected – a total of 6.4 million people, the largest number of any 
country in the world. SA has the second highest annual incidence 
of TB after Swaziland. Approximately 1% of the population develop 
active TB disease each year (an estimated 530 000 people in 2012). 
While SA comprises 0.7% of the world’s population, it is estimated 
that of all cases of HIV-associated TB that occur worldwide annually, 
30% occur here.
Important gains have been made in the public health response 
to HIV in the past decade, but despite these TB and HIV, often as 
co-infection, are still the most important causes of morbidity and 
mortality among adult South Africans. HIV-related complications 
remain the commonest cause for admission to hospital medical 
wards. At Khayelitsha Hospital in Cape Town, over 50% of patients 
admitted to the medical wards are HIV-infected, and many of these 
patients also have active TB. While we have the largest antiretroviral 
therapy (ART) programme in the world, we have not seen the same 
dramatic impact on the prevention of HIV opportunistic infections as 
occurred in industrialised countries when ART was first introduced. 
This important issue of CME, guest edited by Graeme Meintjes, 
addresses the management challenges in tuberculosis and HIV.
Recommendations for amniocentesis 
in HIV-positive women 
All women should be able to opt for prenatal screening and diag-
nosis, and for an amniocentesis if required, regardless of their HIV 
status. Constantatos et al.[1] provide recommendations for amnio-
centesis in HIV-positive women and advise that it is safe to perform 
this procedure in women on highly active antiretroviral therapy 
(HAART) with suppressed viral loads (preferably undetectable) and 
when transplacental passage of the needle is avoided. 
If an HIV-positive patient accepts amniocentesis, HAART 
should be initiated and amniocentesis delayed until the viral load is 
undetectable. If there is not enough time to attain an undetectable 
viral load, however, it is reasonable for the patient to be on HAART 
for as long as possible before amniocentesis. The nature of the fetal 
abnormality may influence the decision to proceed even when the 
viral load is not suppressed – if the abnormality is severe and will 
be associated with significant morbidity, exposing the fetus to a very 
small risk of HIV transmission at amniocentesis is outweighed by the 
benefit of a prenatal diagnosis. 
It is worth noting that there is a non-invasive prenatal screening 
test (the Harmony test) that analyses cell-free DNA in the maternal 
blood and will identify 99% of fetuses with trisomy 21, 97% of fetuses 
with trisomy 18, and 92% of fetuses with trisomy 13. Although not 
available in the state sector or to many private patients because of 
the cost, this highly effective screening test does not carry the risk of 
miscarriage and HIV transmission. 
Premedication for newborns before 
elective intubation
Newborns should be receiving premedication before elective 
intubation,[2] as has become the standard of care in over 90% of 
neonatal units in the UK. Premedication for elective and semi-
urgent intubation of infants significantly improves intubation 
conditions, decreases the time and number of attempts needed to 
complete the intubation procedure, and minimises the potential for 
intubation-related airway trauma that arises from the noxious stimuli 
of intubation, potentially results in raised intracranial pressure, 
hypoxaemia and cardiovascular instability, and may have long-term 
deleterious effects.
Retinoblastoma – early detection 
improves outcome
Kruger et al.[3] report the generally poor outcome in children 
with retinoblastoma at a single institution in SA, reflecting its 
late diagnosis. Overall survival was only 33 - 43%, compared with 
the 95% achievable in developed countries. The simple reason is 
lack of effective screening, and this unacceptably high mortality rate 
can be significantly reduced by the early detection of retinoblastoma 
that may be achieved by ensuring that the ‘red reflex’ is tested for 
on all newborns and toddlers. The ‘red reflex’ or ‘retinal reflex’ 
refers to the reddish-orange reflection of light from normal retina, 
and it is observed with a direct ophthalmoscope held close to the 
examiner’s eye while observing the patient’s eyes from a distance 
of approximately 30 cm. Normally the reflections of the two eyes 
are equivalent in colour, intensity and clarity. Retinoblastoma is 
suggested by a whitening of the reflex, white spots in the reflex, an 
absent red reflex, or asymmetry of the two red reflexes when viewed 
from various angles.
As the editorial by Meyer[4] points out, while retinoblastoma is a 
rare and life-threatening condition, when it is managed optimally 
by a competent health team there is excellent prognosis for survival 
and good visual outcomes. The ‘red reflex’ test should be mandatory 
at discharge from all neonatal services and at all subsequent routine 
health supervision visits. Parents are similarly able to detect a 
problem by noticing an abnormality in the red reflex in photographs 
taken when the ‘red eye reduction’ function happens to be switched 
off on their camera. It would not be too idealistic to suggest that all 
physicians attending to neonates and toddlers use this humble camera 
technique and digitally save the red reflex images to the patient’s 
file at each visit. In the meantime, diabetic screening programmes 
using portable digital imaging systems are already established in 
many areas in the world, including the Cape Town metropole. The 
development of portable digital retinal imaging systems is ongoing, 
and it will be feasible to screen the retinas of all neonates in the future 
using this technology. 
Unwanted pregnancies in Gauteng 
and Mpumalanga
Examining mortality data on dumped aborted fetuses and babies, 
Jacobs et al.[5] report that despite progressive abortion laws, many SA 
women of all ages still appear to be resorting to unsafe terminations 
outside legal, designated facilities. There is an increase in the illegal 
dumping of fetuses and abandoned babies, suggesting an increase 
in unsafe termination practices as well as concealed births. For the 
southern African region (including Botswana, Lesotho, Namibia, SA 
and Swaziland, of which SA forms the major component), 120 000 
unsafe abortions were estimated to have occurred in 2008.
Poor or restricted access to contraceptive services and the fact 
that women experience considerable difficulties in negotiating safe 
sex practices account for unintended pregnancies. Young girls 
who partner with older men are especially vulnerable to sexual 
exploitation because of their financial dependency. 
SA decriminalised abortion in 1996 by introducing the Choice on 
Termination of Pregnancy Act. SA law also protects the individual 
choice of minors, who are encouraged to consult with their parents, 
guardians, family and friends but may terminate a pregnancy without 
parental consent. An undisclosed number of women affected by 
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unwanted pregnancies are nevertheless unable to rely on the existing 
services available. This reflects a lack of information and perceived poor 
quality of services, as well as women being misinformed by hospital 
staff regarding services and legislation. Furthermore, women who are 
able to access these services are stigmatised and report experiencing 
judgemental attitudes from service providers. Accessibility to services 
is further limited because half of the designated facilities that are 
registered providers of termination services are in reality not providing 
this service, reflecting an unwillingness of healthcare workers to be 
trained to undertake termination of pregnancy.
Risks associated with pregnancy in 
young HIV-infected women 
Fatti et al.[6] report that adolescent and young pregnant women are 
at increased risk of mother-to-child transmission of HIV and poor 
maternal and infant health outcomes. An increasing proportion of 
pregnant HIV-positive women in the Nelson Mandela Bay Metropolitan 
district, Eastern Cape Province, SA, are young, and they have poorer 
maternal and infant outcomes than older women. These young women 
are less aware of their HIV status when booking, and had slower 
antenatal ART uptake, reduced uptake of early infant diagnosis, and 
increased mother-to-child transmission (MTCT) of HIV (despite 
having less advanced immunosuppression). Adolescents had increased 
risks of maternal mortality, first presentation in labour and stillbirth, all 
findings that have important public health relevance to SA. 
There is a critical need for sexual and reproductive health rights to 
be rolled out at clinics and schools, to include increased access to HIV 
counselling and testing, barrier methods to prevent transmission, 
and family planning. Interventions targeting young women are 
increasingly needed to reduce pregnancy, HIV infection and MTCT 
and improve maternal and infant outcomes if SA is to attain its 
Millennium Development Goals.
Venous thromboembolism (VTE)  
risk assessment
The Use of VTE prophylaxis in relatioN to patiEnt risk profiling 
(TUNE-IN) Wave 2 study[7] was conducted to evaluate common 
practice in the assessment of VTE risk in the inpatient healthcare 
setting in Gauteng, SA. Public sector patients were more commonly 
clinically assessed as being at risk for VTE than those in the 
private sector (87.0% v. 47.3%), but a greater percentage of patients 
across all risk levels received prophylaxis in the private than in the 
public sector (96.8% v. 79.7%), possibly as a result of availability of 
chemoprophylaxis drug preparations, costs and VTE prophylaxis 
protocols.
There is a need for improvement in VTE risk assessment and 
prophylaxis in both the public and private sectors. The implementation 
of a formalised VTE risk assessment tool – as outlined in the 
article – will ensure standardisation of VTE risk assessment and 
administration of adequate prophylaxis.
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CORRESPONDENCE
Insulin receptor substrate-1 
Gly972Arg variant and type 2  
diabetes mellitus
To the Editor: In their article, Vergotine et al.[1] concluded that 
‘the Gly972Arg variant may not aid diabetes risk evaluation in 
this setting’. In fact, the insulin receptor substrate-1 Gly972Arg 
variant is widely studied in terms of its relationship to diabetes 
mellitus. Different observations have been made in different 
settings. In a report from Mexico, Burguete-Garcia et al.[2] found 
‘participation of Gly972Arg polymorphism of IRS1 in the genetic 
susceptibility to TD2 in Mexican population’. An interesting 
point is that there are many possible genetic polymorphisms that 
can relate to diabetes mellitus. However, a polymorphism study 
alone cannot tell the exact relationship. In a previous study from 
Mexico,[3] a polygenic polymorphism effect on diabetes could be 
confirmed.
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